Inceptor Bio
Derek Hennecke is a partner in the Kineticos Disruptor Fund, a fund focused on disruptive, platform technologies addressing unmet medical needs. Derek was also the Founder and CEO of Xcelience, a Florida-based contract development and manufacturing company that specialized in developing clinical Phase I-III drug product. He started the company in 2006 and sold it to a large multinational in 2016. He is currently a Board Member for The Friedreich's Ataxia Research Alliance. Derek received his BSC from the University of Alberta and his MBA from RSM Erasmus Universiteit.
This person is not in the org chart
This person is not in any offices
Inceptor Bio
Inceptor Bio’s vision is to improve the way difficult-to-cure cancers are treated, changing patients’ lives with breakthrough cell and gene therapies.